McKesson Corp (MCK) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 880.01 at 4:00 am ET, low 868.03 at 10:45 am ET.
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
the bull case· 4
2,018
managers reporting a position in thirteen F filings
13fJun 30 '2610
funds on file reporting a position in MCK
n-portas of Jun 30 '2678
managers whose positions make up four fifths of reported value
13fJun 30 '261.58%
State Street Health Care Select Sector SPDR ETF's largest fund weight on file
n-portJun 30 '26the bear case· 4
73.00%
revenue from the largest disclosed customer among ten largest combined
10-Kfiled May 8 '2631.00%
of Pacira BioSciences Inc.'s revenue is MCK per their filing
10-Kfrom their filing11 of 22
largest reporting managers that cut their stake in the latest quarter
13fJun 30 '26−1.05%
change in shares held by the ten largest reporting managers over latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 3 '26 report. Not a forecast, not advice.
Of the 6 companies McKesson Corp moves with most closely, 2 also share its SEC classification.
Measured against 501 trading days of our own closes. Co-movement, not cause.
SIC 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries, from each company's own filings. Largest first.
A rule beside a ticker marks a company that appears in both readings.
Which of these the filings never mention ›McKesson Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries
2,018 managers report a position worth $80.0B between them, and 78 of them hold 80% of it.
tall tick = annual report · 2 on record
MCK (McKesson Corp) has 14 disclosed suppliers and 7 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.